U.S. Gains COVID-19 Drug Monopoly for Gilead’s 31,900% Markup

U.S. Gains COVID-19 Drug Monopoly for Gilead’s 31,900% Markup

The U.S. government and Gilead have colluded in the fleecing of taxpayers by agreeing a huge 31,900% markeup for Covid-19 drug remdesivir.
Read More